GTCbio is proud to announce its 5th Immunogenicity & Immunotoxicity Conference, one of three parallel tracks to the ImmunoTX Summit on February 6-7, 2017 in San Diego, CA. The conference will cover important progress made in the areas of therapeutic protein immunogenicity and immunotoxicity evaluation such as protein aggregation, clinical relevance and assessment of immunogenicity, mitigation of immunogenicity-related risks, biosimilar development, and immunotoxicity evaluation strategies.
The Immunogenicity and Immunotoxicity Conference aims to bring together leading experts from academia and industry to discuss ongoing research on the immunogenicity and immunotoxicity of therapeutic proteins. Together, we will examine the mechanisms and consequences of immunogenicity, as well as the novel tools and techniques to predict, assess, and modulate immunogenicity and immunotoxicity.
I. Molecular Mechanisms of Immunogenicity
II. Strategic Modulation of Immunogenicity
III. Immunogenicity Assessment of Novel Drug Candidates and Biosimilars
We hope to see you there!
The 2017 Organizing Committee